Life Sciences Times

NTx Appoints RNA Biology Pioneer Dr. Jeff Coller to Scientific Advisory Board

FDA Approves Johnson & Johnson’s INLEXZO™ for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Apollo Therapeutics Reports Positive Phase 2a Results for Camoteskimab in Atopic Dermatitis

Tasca Therapeutics Doses First Patient in Phase 1/2 Trial of CP-383 in Advanced Solid Tumors

Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-250 for Myeloid Malignancies

Enveric Biosciences Prepares IND Filing for EB-003 Following FDA Response

Flavia Pease to Become Chief Financial Officer of Insulet

Mercy Ships Appoints Dr. Michelle White as Chief Executive Officer

Transcarent Names Dr. Alan Roga as Chief Clinical Officer

Worldwide Clinical Trials Appoints Alistair Macdonald as Chief Executive Officer